<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The antiphospholipid (Hughes) syndrome (APS) includes systemic and central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) pathology associated with antibodies to a complex of <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta2-GPI) </plain></SENT>
<SENT sid="1" pm="."><plain>Beta2-GPI immunized mice develop systemic manifestations of APS and we presently examined <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> manifestations in this APS model </plain></SENT>
<SENT sid="2" pm="."><plain>Female BALB/c mice were immunized once with beta2-GPI in complete Freund's adjuvant (CFA) or with CFA alone (controls) </plain></SENT>
<SENT sid="3" pm="."><plain>A staircase test and a T-maze alternation test were performed to test behavior and cognition in independent groups of mice 6, 12 and 18 weeks following the immunization </plain></SENT>
<SENT sid="4" pm="."><plain>The APS mice developed elevated levels of antibodies against negatively charged <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and beta2-GPI </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological impairment was detected only 18 weeks after the induction of the APS and consisted of both cognitive (53 +/- 4 vs 71 +/- 3% correct choices in the T-maze alternation for APS vs control mice, P &lt; 0.001) and <z:hpo ids='HP_0000708'>behavioral changes</z:hpo> (higher number of rears (18 +/- 2 vs 11 +/- 1, P &lt; 0.006) and higher number of stairs climbed (12 +/- 2 vs 7 +/- 1, P &lt; 0.02) </plain></SENT>
<SENT sid="6" pm="."><plain>This is the first report of <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> in this APS model and demonstrates the time course for the development of previously described <z:hpo ids='HP_0000708'>behavioral changes</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The mechanism involved in these <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> manifestations remains to be elucidated </plain></SENT>
</text></document>